Enhancing sequencing capacity for AMR surveillance and emerging pathogen detection through acquisition of the illumina miseq I100
Active Cooperative Agreement Awarded Last action
- Award ID
- U18FD008916
- Recipient
-
Board Of Regents Of The University Of Nebraska UEI HTQ6K6NJFHA6
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $60,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 18% complete
- Funding agency
- Food and Drug Administration Department of Health and Human Services
- Place of performance
- Nebraska, USA
Award details come from USAspending.gov.
Description
- Abstract
- The nebraska veterinary diagnostic center (NVDC) seeks VET-lirn capacity building grant support to acquire an illumina miseq I100 sequencing platform to enhance whole-genome sequencing (WGS) capabilities, expand antimicrobial resistance (AMR) surveillance, and strengthen diagnostic capacity and response to unknown or emerging pathogen outbreaks. As a VET-lirn network laboratory, NVDC plays a key role in bacterial pathogen detection, AMR monitoring, and diagnostic support for animal food safety and one health investigations. The miseq I100 will significantly increase our sequencing throughput and improve the resolution, accuracy, and timeliness of genomic data generated for veterinary, one health, and foodborne pathogens. The illumina miseq I100 provides several key advantages over the current illumina iseq 100 platform, representing a meaningful enhancement to NVDC's sequencing capacity. In addition to delivering higher throughput and improved data quality, the miseq I100 offers significantly expanded data output, with a run capacity ranging from 1.5 GB to 30 GB, far exceeding the output limits of the iseq 100 and enabling higher sample throughput and deeper sequencing for a wider range of applications. Its reagent cartridges are designed for storage at room temperature throughout their three-month shelf life, eliminating the need for freezer storage, reducing associated costs, and simplifying laboratory logistics. This added capacity will support VET-lirn's mission by improving our ability to respond quickly to diagnostic case investigations and to contribute high-quality genomic data to national AMR and surveillance datasets. The instrument will also enhance diagnostic readiness during outbreak events by enabling accelerated sequencing turnaround and more comprehensive genomic insights. This equipment will bolster NVDC's contributions to one health surveillance and improve coordination and collaboration between veterinary, public health, and agricultural partners and VET-lirn network laboratories. Overall, the acquisition of the miseq I100 represents a critical modernization of NVDC's sequencing infrastructure, enabling more effective monitoring, investigation, and prevention of pathogen threats that impact both animal and human health.
Quick answers
Who received award U18FD008916?
U18FD008916 was awarded to Board Of Regents Of The University Of Nebraska by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.
How much is award U18FD008916 worth?
$60,000 has been obligated on U18FD008916.
Which agency awarded U18FD008916?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008916, with funding from Food and Drug Administration (Department of Health and Human Services).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award